Opening book details…
Can I read Prevalence and Clinical Implications of Sleep Apneain Hypertrophic Cardiomyopathy on EtoBox?
Prevalence and Clinical Implications of Sleep Apneain Hypertrophic Cardiomyopathy by Shahid Karim, MBChB, PhD; Anwar Chahal, MBChB, PhD; Shreyas Venkataraman, MBBS; is a book available to read on EtoBox.
What is Prevalence and Clinical Implications of Sleep Apneain Hypertrophic Cardiomyopathy about?
IMPORTANCE Sleep disordered breathing (SDB) is a well-established contributor tocardiovascular morbidity, mediated by intermittent hypoxemia, autonomic dysregulation,and endothelial dysfunction. Patients with hypertrophic cardiomyopathy (HCM) may beespecially at risk for SDB, but the clinical impact of SDB in this population remains unclear.OBJECTIVE To define the prevalence and subtypes of SDB in HCM and examine theirassociation with echocardiographic parameters and cardiac biomarker expression.DESIGN, SETTING, AND PARTICIPANTS A prospective cohort study was conducted betweenApril 18, 2018, and January 15, 2024, at a single tertiary referral center specializing in HCMcare. Adults with HCM (left ventricular wall thickness 15 mm or pathogenic variants) wererecruited from an institutional registry. Patients diagnosed with SDB or current pregnancywere excluded. Patients underwent polysomnography, with comparative assessment ofechocardiographic, electrocardiographic, and biomarker indices. Observers were blinded topolysomnographic results. Data analysis was performed from April 11, 2024, to July 25, 2024.EXPOSURES SDB classified via polysomnography using apnea-hypopnea index threshold
- Author
- Shahid Karim, MBChB, PhD; Anwar Chahal, MBChB, PhD; Shreyas Venkataraman, MBBS;
- Published
- 2025
- Language
- EN
More by Shahid Karim, MBChB, PhD; Anwar Chahal, MBChB, PhD; Shreyas Venkataraman, MBBS;
Browse all works by Shahid Karim, MBChB, PhD; Anwar Chahal, MBChB, PhD; Shreyas Venkataraman, MBBS;
Similar books
- Hypertrophic Cardiomyopathy — William M. DeCampli; Kamal K. Pourmoghadam (2023)
- Hypertension and Hypertrophic Cardiomyopathy — Andrew Wang (2018)
- Hypertrophic Cardiomyopathy (cardiomyopathy Update) (v. 2) — Hironori Toshima; Barry J Maron; Yoshinori Koga (1988)
- CRISPR Gene-editing Therapies for Hypertrophic Cardiomyopathy — Alanna Strong (2023)
- Regulatory T Cells Protect the Heart in Hypertrophic Cardiomyopathy — x (2025)
- Ischemic Cardiomyopathy: Contemporary Clinical Management — Burhan Sheikh Alkar; Gustav Mattsson; Peter Magnusson (2018)